At the IFA Berlin 2026, Singapore’s health tech company Actxa unveiled its latest innovation, the Spark Band, a screenless wearable designed for comprehensive health monitoring. This device integrates sleep, heart health, activity, and fitness tracking with Actxa’s proprietary non-invasive glucose awareness technology. The Spark Band employs BGEM technology to deliver an AI Glucose Snapshot, offering users an estimated glucose range in about a minute. While this feature is meant for general wellness, Actxa emphasizes that it is not a substitute for medical diagnosis or treatment.
Users can utilize the snapshot feature at various times, such as before and after meals, to track glucose patterns over time. Actxa’s strategy encourages users to focus on health trends rather than isolated readings, integrating this data with other lifestyle information. Alongside glucose monitoring, the Spark Band tracks several health metrics via the Actxa app, including sleep stages, sleep scores, and heart rate variability (HRV) for recovery analysis. For fitness enthusiasts, it monitors movement, intensity minutes, and provides insights into workouts, VO2 Max, and Fitness Age. The device also includes a Target Heart Rate Zone alert, using LED and vibration signals to keep users informed of their training intensity without a screen display.
Designed for continuous day-and-night wear, the Spark Band boasts a minimalist design to minimize wrist notifications and distractions. It is lightweight at 22 grams and features a zinc-alloy casing with a soft nylon braided strap. The band is available in Titanium Silver with Jet Black accents and a Midnight Black strap, catering to different wrist sizes. Rated IP68 for water resistance, it can withstand everyday water exposure, including brief immersion. The battery lasts up to 14 days, and a full charge takes approximately 90 minutes. Connectivity is facilitated through Bluetooth Low Energy, compatible with Android 8.0 and iOS 15.6 or later, and it does not require a subscription.
The Spark Band will be available for pre-order starting September 24, 2026, priced at SGD 199 / USD 149, with the official launch on November 18, 2026. Actxa plans to introduce the device across select markets in Asia Pacific, Europe, the Middle East, and North America. During the pre-order phase, customers can benefit from promotional discounts, including a 40% early-bird offer until October 31, followed by a 20% discount until November 17, and a 10% launch offer post-official release. Actxa reiterates that the AI Glucose Snapshot is solely for wellness and awareness, not for medical use.
Since its inception in 2015, Actxa Pte Ltd has been at the forefront of health and wellness technology, developing devices and technologies aimed at enhancing personal health monitoring. The company is committed to providing innovative solutions for general wellness applications, with a focus on non-invasive health tracking. For more information, Actxa can be reached via their website or through their communications email.
Legal Disclaimer: The information contained in this article has been provided by independent third-party contributors, clients, or content partners. We do not independently verify the accuracy, completeness, legality, ownership, licensing, or reliability of submitted content, including text, images, videos, trademarks, or other media materials. The submitting party is solely responsible for ensuring that all content, including images and media assets, complies with applicable copyright, trademark, licensing, and intellectual property laws. We disclaim liability for any unauthorized use of copyrighted or proprietary materials by third parties. If you believe that any content published on this platform infringes your intellectual property rights, kindly contact the author above for prompt review and resolution.